引用本文:[点击复制]
[点击复制]
【打印本页】 【在线阅读全文】【下载PDF全文】 查看/发表评论下载PDF阅读器关闭

←前一篇|后一篇→

过刊浏览    高级检索

本文已被:浏览 180次   下载 12 本文二维码信息
码上扫一扫!
SIS镁合金可吸收胆管支架治疗恶性梗阻性黄疸疗效分析
宋勇,秦高平,杜立学,胡海田,张昊宇
0
(陕西省人民医院·西安交通大学第三附属医院;烧伤整形美容外科)
摘要:
【摘要】目的 分析SIS镁合金可吸收胆管支架治疗恶性梗阻性黄疸的临床疗效。方法 选取67例接受胆道金属支架引流术(EBMSD)的恶性梗阻性黄疸患者,按照置入不同金属支架分为对照组和实验组,对照组患者置入普通镍钛合金支架,实验组患者置入SIS镁合金可吸收支架。检测两组患者术前1周及术后1周血清总胆红素(TBIL)、丙氨酸转氨酶(ALT)、碱性磷酸酶(ALP)、天门冬氨酸氨基转移酶(AST)、直接胆红素(DBIL)和间接胆红素(IBIL),观察两组患者术后并发症情况及两组患者6个月生存率和引流通畅率。结果 对照组插管成功率为91.7%,实验组患者插管成功率为93.5%,两组对比无明显差异(P>0.05);两组患者术后1周肝功能指标(TBIL,ALT,ALP,AST,DBIL,IBIL)明显优于术前1周(P<0.05),但两组之间术后1周肝功能指标对比无明显差异(P>0.05);实验组患者术后并发症明显低于对照组患者(P<0.05);实验组患者6个月生存率为82.3%,引流通畅率为72.4%,明显优于对照组患者的66.7%和39.4%(P<0.05)。结论 SIS镁合金可吸收胆管支架能有效缓解患者恶性梗阻性黄疸症状,改善肝功能,延长患者生存期;术后并发症低于普通镍钛合金支架。
关键词:  SIS镁合金  可吸收  胆管支架  恶性梗阻性黄疸
DOI:
基金项目:中国博士后第55批自然科学基金(2014M552459);西安市自然科学基金(2012D37)
Study of the clinical effect of SIS magnesium alloy absorbable biliary stent in treatment of patients with malignant obstructive jaundice
SONG Yong,QIN Gaoping,DU Lixue,HU Haitian,ZHANG Haoyu
(Department of Hepatobiliary Surgery, Shanxi People's Hospital·The Third Affiliated Hospital of Xi'an Jiao Tong University;Department of Burns and Plastic Surgery, Shanxi People's Hospital·The Third Affiliated Hospital of Xi'an Jiao Tong University)
Abstract:
【Abstract】Objective To investigate the clinical effect of SIS magnesium alloy absorbable biliary stent in the treatment of patients with malignant obstructive jaundice. Methods 67 patients with malignant obstructive jaundice treated with EBMSD in our hospital were selected and divided into control group and observation group according to the different metal biliary stent. The patients in control group accepted normal Nickel titanium alloy stent while the patients in observation group accepted magnesium alloy absorbable biliary stent. The TBIL, ALT, ALP, AST, DBIL, IBIL of all the patients were detected before and after one week of the operation. The complication after operation, survival rate and drainage unobstructed rate after 6 months were observed. Results The stents placing successful rate of control group was 917% and 93.5% for observation group (P>0.05). After operation, TBIL, ALT, ALP, AST, DBIL, IBIL of the two groups were better than those before operation and there was no significant difference between the two groups (P>0.05). On the other hand, more complications was observed in the control groups (P<0.05). After 6 months, the survival rate of observation group was 82.3% and drainage unobstructed rate was 72.4, which were better than those in control group (P<0.05). Conclusion SIS magnesium alloy absorbable biliary stent could improve the liver function and reduce the malignant obstructive jaundice symptoms and longer the life of the patients with malignant obstructive jaundice.
Key words:  SIS magnesium alloy  Absorbable  Biliary stent  Malignant obstructive jaundice

用微信扫一扫

用微信扫一扫